10 research outputs found
Behavior of respiratory syncytial virus in piglet tracheal organ culture
No full textPiglet tracheal organ cultures were infected with respiratory syncytial virus (RSV) and observed for 21 days. Light and immunofluorescence microscopy demonstrated destruction of the ciliated epithelial cells and the presence of viral antigens in the epithelium. Virus was shed in high titer for 12-19 days. Ciliostasis could be quanti-tated, and it was shown that several strains of RSV grew and damaged tracheal organ cultures in a similar fashion. A temperature-sensitive mutant of RSV, Is-I, was exam-ined at permissive (33 C) and restrictive (37 C) temperatures. This mutant, al-though somewhat attenuated at 37 C, was still found to cause damage to the ciliated epithelium and to replicate at both temperatures. This behavior is similar to that af-ter inoculation of Is-I into volunteers. This in vitro model may prove useful in the study of RSV disease and in the evaluation of candidate live virus vaccines. Respiratory syncytial virus (RSV) is the most important etiologic agent of lower respiratory tract disease in infancy [1]. Studies of human RSV using animal models have been of limite
Comparative Effects of Arabinosyl Nucleosides upon the Postnatal Growth and Development of the Rat
No full textDetection of Respiratory Syncytial Virus in Nasal Secretions from Infants by Enzyme-Linked Immunosorbent Assay
No full text942 IMMUNOLOGY OF BREAST MILK: ORIGIN OF ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS (RSV) AND BOVINE SERUM ALBUMIN (BSA) IN THE LACTATING BREAST
No full textInterleukin 7 from maternal milk crosses the intestinal barrier and modulates T-cell development in offspring
No full textBackground
Breastfeeding protects against illnesses and death in hazardous environments, an
effect partly mediated by improved immune function. One hypothesis suggests that
factors within milk supplement the inadequate immune response of the offspring,
but this has not been able to account for a series of observations showing that
factors within maternally derived milk may supplement the development of the
immune system through a direct effect on the primary lymphoid organs. In a
previous human study we reported evidence suggesting a link between IL-7 in
breast milk and the thymic output of infants. Here we report evidence in mice of
direct action of maternally-derived IL-7 on T cell development in the offspring.
Methods and Findings
We have used recombinant IL-7 labelled with a fluorescent dye to trace the
movement in live mice of IL-7 from the stomach across the gut and into the
lymphoid tissues. To validate the functional ability of maternally derived IL-
7 we cross fostered IL-7 knock-out mice onto normal wild type mothers. Subsets
of thymocytes and populations of peripheral T cells were significantly higher
than those found in knock-out mice receiving milk from IL-7 knock-out mothers.
Conclusions/Significance Our study provides direct evidence that interleukin 7,
a factor which is critical in the development of T lymphocytes, when maternally
derived can transfer across the intestine of the offspring, increase T cell
production in the thymus and support the survival of T cells in the peripheral
secondary lymphoid tissue.PLoS ON
Effect of Immunization Against Rubella on Lactation Products. I. Development and Characterization of Specific Immunologic Reactivity in Breast Milk
No full textEffect of Immunization Against Rubella on Lactation Products. II. Maternal-Neonatal Interactions
No full text
The development of recombinant Adenoviral vaccines to target pneumovirus infection
No full textRespiratory Syncytial Virus (RSV) is a member of the pneumovirus genus (family
Paramyxoviridae, subfamily Pneumovirinae). RSV is an important respiratory virus
of both infants and the elderly, representing an underappreciated burden on health
care systems. In addition, re-infections can occur despite the presence of pre-existing
immunity, suggesting that immunological memory to RSV is incomplete.
To date, treatment of RSV infection is limited to the provision of supportive care and
no effective vaccine is available. Although several are currently under investigation,
these candidates focus upon the delivery of the F and G antigens of RSV to stimulate
the immune system, rather than the internal antigens, which may provide cross
protection between different subtypes of RSV.
Vaccine development has been greatly hindered by the lack of an appropriate animal
model in which to study vaccine efficacy and pneumovirus pathogenesis. Pneumonia
virus of mice (PVM) is also a member of the Pneumovirus genus and, like RSV
infection of humans, causes a bronchiolitis and fatal pneumonia in its natural host,
the mouse. PVM has been proposed as an appropriate model system in which to both
study pneumovirus pathogenesis and vaccine efficacy.
The PVM model system was adapted to investigate a potential vaccination strategy
to address the lack of an available RSV vaccine. Replication deficient recombinant
adenovirus serotype 5 (rAd5) vectors were constructed which expressed the F, M and
N genes of PVM J3666, in addition to a control construct, which expressed the LacZ
gene of E. coli.
The constructs were administered via the intranasal route to BALB/c mice and were
able to elicit complete protection against a lethal dose of pathogenic PVM J3666, in
both short-term experiments and in a long-term experiment, up to 20 weeks post
immunisation. The protection effect elicited by the constructs was observed when
administered in a single dose, and in alternative mouse strains, C3H/He-mg and
C57BL/6, which had differing immunity haplotypes.
The rAd5 vectors generated a PVM specific IgG humoral response to PVM and Ad5
antigen which did not correlate as the primary mediator of protection. The rAd5
candidate expressing the N gene of PVM was shown to induce IFNγ secreting T-cells.
The use of a peptide library of PVM N protein determined that a specific response
could be identified towards the amino acids N41-90, N81-130, N161-210 and N281-330. Thus,
the PVM infection model of BALB/c mice provides an immunological platform to
facilitate the study of RSV and PVM pathogenesis, immunology and vaccine
development
